US Stock MarketDetailed Quotes

Aclaris Therapeutics (ACRS)

Watchlist
  • 4.520
  • -0.280-5.83%
Trading May 15 15:57 ET
631.28MMarket Cap-8.07P/E (TTM)

Aclaris Therapeutics (ACRS) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
0.10%105.42M
-20.11%90.75M
-20.11%90.75M
-24.91%95.91M
-10.16%99.81M
-17.83%105.31M
-4.63%113.59M
-4.63%113.59M
23.94%127.72M
-7.25%111.09M
-Cash and cash equivalents
-5.59%28.66M
-18.76%19.96M
-18.76%19.96M
-47.00%25.26M
11.25%25.4M
-15.30%30.36M
-38.39%24.57M
-38.39%24.57M
22.06%47.65M
-26.70%22.83M
-Short-term investments
2.40%76.76M
-20.48%70.79M
-20.48%70.79M
-11.76%70.66M
-15.70%74.4M
-18.81%74.96M
12.36%89.02M
12.36%89.02M
25.09%80.07M
-0.41%88.26M
Receivables
----
----
----
1,264.43%4.68M
-40.31%194K
-32.98%250K
6.71%318K
6.71%318K
-0.87%343K
-24.59%325K
-Accounts receivable
----
----
----
1,264.43%4.68M
-40.31%194K
-32.98%250K
6.71%318K
6.71%318K
-0.87%343K
-24.59%325K
Other current assets
49.23%4.81M
-54.96%5.57M
-54.96%5.57M
----
-32.41%4.2M
-52.55%3.23M
30.73%12.36M
30.73%12.36M
-78.32%4.27M
-51.16%6.22M
Total current assets
1.32%110.23M
-23.53%96.32M
-23.53%96.32M
-23.98%100.59M
-11.42%104.2M
-19.62%108.79M
-2.25%125.95M
-2.25%125.95M
7.53%132.33M
-11.51%117.64M
Non current assets
Net PPE
-20.38%750K
-24.50%761K
-24.50%761K
-28.42%811K
-32.87%868K
-38.47%942K
-37.78%1.01M
-37.78%1.01M
-35.77%1.13M
-31.91%1.29M
-Gross PPE
----
----
----
-0.31%5.8M
1.12%5.88M
-0.24%5.86M
0.54%5.81M
0.54%5.81M
-8.72%5.81M
-7.85%5.81M
-Accumulated depreciation
----
----
----
-6.50%-4.98M
-10.84%-5.01M
-13.25%-4.91M
-15.45%-4.81M
-15.45%-4.81M
-1.65%-4.68M
-2.52%-4.52M
Investments and advances
0.19%85.37M
-32.88%60.61M
-32.88%60.61M
55.96%71.3M
109.10%81.08M
156.67%85.21M
43.86%90.3M
43.86%90.3M
-45.54%45.71M
-57.38%38.78M
Other non current assets
-24.85%2.37M
-9.62%2.77M
-9.62%2.77M
-11.91%2.83M
-11.05%2.99M
-21.17%3.15M
-26.26%3.07M
-26.26%3.07M
20.89%3.22M
16.52%3.37M
Total non current assets
-0.91%88.49M
-32.03%64.14M
-32.03%64.14M
49.69%74.94M
95.56%84.95M
130.60%89.3M
37.68%94.38M
37.68%94.38M
-47.46%50.06M
-57.71%43.44M
Total assets
0.32%198.72M
-27.17%160.46M
-27.17%160.46M
-3.76%175.53M
17.43%189.15M
13.80%198.09M
11.61%220.33M
11.61%220.33M
-16.47%182.39M
-31.65%161.07M
Liabilities
Current liabilities
Payables
131.84%14.73M
180.55%13.16M
180.55%13.16M
19.90%9.19M
21.02%8.8M
-41.22%6.35M
-47.17%4.69M
-47.17%4.69M
-20.58%7.66M
-36.38%7.27M
-accounts payable
131.84%14.73M
180.55%13.16M
180.55%13.16M
19.90%9.19M
21.02%8.8M
-41.22%6.35M
-47.17%4.69M
-47.17%4.69M
-20.58%7.66M
-36.38%7.27M
Current accrued expenses
2.91%3.85M
-69.43%3.49M
-69.43%3.49M
72.53%3.66M
-10.18%3.26M
-23.12%3.75M
-26.45%11.43M
-26.45%11.43M
-79.21%2.12M
-25.11%3.62M
Current deferred liabilities
-43.11%3.97M
-49.56%3.94M
-49.56%3.94M
67.25%6.3M
--9.33M
--6.98M
--7.82M
--7.82M
--3.77M
----
Other current liabilities
2.63%2.77M
2.61%2.75M
2.61%2.75M
2.55%2.74M
2.49%2.72M
-0.18%2.7M
2.09%2.68M
2.09%2.68M
21.12%2.67M
20.39%2.65M
Current liabilities
27.22%27.37M
-9.34%28.65M
-9.34%28.65M
36.22%25.63M
71.15%26.84M
7.14%21.51M
2.08%31.6M
2.08%31.6M
-31.13%18.82M
-31.31%15.68M
Non current liabilities
Non current deferred liabilities
-20.42%15.29M
-19.31%16.17M
-19.31%16.17M
-17.42%17.49M
--18.22M
--19.21M
--20.04M
--20.04M
5,671.66%21.18M
----
Other non current liabilities
-6.70%12.42M
-4.37%12.57M
-4.37%12.57M
0.54%12.31M
6.78%12.35M
11.17%13.31M
41.68%13.14M
41.68%13.14M
-64.34%12.25M
-64.63%11.57M
Total non current liabilities
-14.80%27.7M
-13.39%28.73M
-13.39%28.73M
-10.84%29.8M
164.28%30.57M
171.61%32.51M
257.74%33.18M
257.74%33.18M
-3.67%33.43M
-65.02%11.57M
Total liabilities
1.93%55.07M
-11.42%57.38M
-11.42%57.38M
6.11%55.43M
110.68%57.41M
68.57%54.03M
61.02%64.77M
61.02%64.77M
-15.77%52.24M
-51.25%27.25M
Shareholders'equity
Share capital
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
-common stock
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
0.00%1K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-7.59%-987.61M
-7.19%-967.78M
-7.19%-967.78M
-17.57%-947.99M
-16.86%-933.38M
-16.53%-917.95M
-17.13%-902.86M
-17.13%-902.86M
-4.81%-806.31M
-7.93%-798.72M
Paid-in capital
6.56%1.13B
1.13%1.07B
1.13%1.07B
14.04%1.07B
14.11%1.06B
14.13%1.06B
14.03%1.06B
14.03%1.06B
1.00%936.03M
1.31%933.01M
Gains losses not affecting retained earnings
-94.93%22K
528.87%610K
528.87%610K
39.81%597K
204.10%482K
219.23%434K
191.51%97K
191.51%97K
137.82%427K
58.33%-463K
Total stockholders'equity
-0.29%143.65M
-33.73%103.08M
-33.73%103.08M
-7.72%120.1M
-1.56%131.74M
1.44%144.07M
-1.03%155.55M
-1.03%155.55M
-16.75%130.15M
-25.55%133.82M
Total equity
-0.29%143.65M
-33.73%103.08M
-33.73%103.08M
-7.72%120.1M
-1.56%131.74M
1.44%144.07M
-1.03%155.55M
-1.03%155.55M
-16.75%130.15M
-25.55%133.82M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 0.10%105.42M-20.11%90.75M-20.11%90.75M-24.91%95.91M-10.16%99.81M-17.83%105.31M-4.63%113.59M-4.63%113.59M23.94%127.72M-7.25%111.09M
-Cash and cash equivalents -5.59%28.66M-18.76%19.96M-18.76%19.96M-47.00%25.26M11.25%25.4M-15.30%30.36M-38.39%24.57M-38.39%24.57M22.06%47.65M-26.70%22.83M
-Short-term investments 2.40%76.76M-20.48%70.79M-20.48%70.79M-11.76%70.66M-15.70%74.4M-18.81%74.96M12.36%89.02M12.36%89.02M25.09%80.07M-0.41%88.26M
Receivables ------------1,264.43%4.68M-40.31%194K-32.98%250K6.71%318K6.71%318K-0.87%343K-24.59%325K
-Accounts receivable ------------1,264.43%4.68M-40.31%194K-32.98%250K6.71%318K6.71%318K-0.87%343K-24.59%325K
Other current assets 49.23%4.81M-54.96%5.57M-54.96%5.57M-----32.41%4.2M-52.55%3.23M30.73%12.36M30.73%12.36M-78.32%4.27M-51.16%6.22M
Total current assets 1.32%110.23M-23.53%96.32M-23.53%96.32M-23.98%100.59M-11.42%104.2M-19.62%108.79M-2.25%125.95M-2.25%125.95M7.53%132.33M-11.51%117.64M
Non current assets
Net PPE -20.38%750K-24.50%761K-24.50%761K-28.42%811K-32.87%868K-38.47%942K-37.78%1.01M-37.78%1.01M-35.77%1.13M-31.91%1.29M
-Gross PPE -------------0.31%5.8M1.12%5.88M-0.24%5.86M0.54%5.81M0.54%5.81M-8.72%5.81M-7.85%5.81M
-Accumulated depreciation -------------6.50%-4.98M-10.84%-5.01M-13.25%-4.91M-15.45%-4.81M-15.45%-4.81M-1.65%-4.68M-2.52%-4.52M
Investments and advances 0.19%85.37M-32.88%60.61M-32.88%60.61M55.96%71.3M109.10%81.08M156.67%85.21M43.86%90.3M43.86%90.3M-45.54%45.71M-57.38%38.78M
Other non current assets -24.85%2.37M-9.62%2.77M-9.62%2.77M-11.91%2.83M-11.05%2.99M-21.17%3.15M-26.26%3.07M-26.26%3.07M20.89%3.22M16.52%3.37M
Total non current assets -0.91%88.49M-32.03%64.14M-32.03%64.14M49.69%74.94M95.56%84.95M130.60%89.3M37.68%94.38M37.68%94.38M-47.46%50.06M-57.71%43.44M
Total assets 0.32%198.72M-27.17%160.46M-27.17%160.46M-3.76%175.53M17.43%189.15M13.80%198.09M11.61%220.33M11.61%220.33M-16.47%182.39M-31.65%161.07M
Liabilities
Current liabilities
Payables 131.84%14.73M180.55%13.16M180.55%13.16M19.90%9.19M21.02%8.8M-41.22%6.35M-47.17%4.69M-47.17%4.69M-20.58%7.66M-36.38%7.27M
-accounts payable 131.84%14.73M180.55%13.16M180.55%13.16M19.90%9.19M21.02%8.8M-41.22%6.35M-47.17%4.69M-47.17%4.69M-20.58%7.66M-36.38%7.27M
Current accrued expenses 2.91%3.85M-69.43%3.49M-69.43%3.49M72.53%3.66M-10.18%3.26M-23.12%3.75M-26.45%11.43M-26.45%11.43M-79.21%2.12M-25.11%3.62M
Current deferred liabilities -43.11%3.97M-49.56%3.94M-49.56%3.94M67.25%6.3M--9.33M--6.98M--7.82M--7.82M--3.77M----
Other current liabilities 2.63%2.77M2.61%2.75M2.61%2.75M2.55%2.74M2.49%2.72M-0.18%2.7M2.09%2.68M2.09%2.68M21.12%2.67M20.39%2.65M
Current liabilities 27.22%27.37M-9.34%28.65M-9.34%28.65M36.22%25.63M71.15%26.84M7.14%21.51M2.08%31.6M2.08%31.6M-31.13%18.82M-31.31%15.68M
Non current liabilities
Non current deferred liabilities -20.42%15.29M-19.31%16.17M-19.31%16.17M-17.42%17.49M--18.22M--19.21M--20.04M--20.04M5,671.66%21.18M----
Other non current liabilities -6.70%12.42M-4.37%12.57M-4.37%12.57M0.54%12.31M6.78%12.35M11.17%13.31M41.68%13.14M41.68%13.14M-64.34%12.25M-64.63%11.57M
Total non current liabilities -14.80%27.7M-13.39%28.73M-13.39%28.73M-10.84%29.8M164.28%30.57M171.61%32.51M257.74%33.18M257.74%33.18M-3.67%33.43M-65.02%11.57M
Total liabilities 1.93%55.07M-11.42%57.38M-11.42%57.38M6.11%55.43M110.68%57.41M68.57%54.03M61.02%64.77M61.02%64.77M-15.77%52.24M-51.25%27.25M
Shareholders'equity
Share capital 0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K
-common stock 0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K0.00%1K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -7.59%-987.61M-7.19%-967.78M-7.19%-967.78M-17.57%-947.99M-16.86%-933.38M-16.53%-917.95M-17.13%-902.86M-17.13%-902.86M-4.81%-806.31M-7.93%-798.72M
Paid-in capital 6.56%1.13B1.13%1.07B1.13%1.07B14.04%1.07B14.11%1.06B14.13%1.06B14.03%1.06B14.03%1.06B1.00%936.03M1.31%933.01M
Gains losses not affecting retained earnings -94.93%22K528.87%610K528.87%610K39.81%597K204.10%482K219.23%434K191.51%97K191.51%97K137.82%427K58.33%-463K
Total stockholders'equity -0.29%143.65M-33.73%103.08M-33.73%103.08M-7.72%120.1M-1.56%131.74M1.44%144.07M-1.03%155.55M-1.03%155.55M-16.75%130.15M-25.55%133.82M
Total equity -0.29%143.65M-33.73%103.08M-33.73%103.08M-7.72%120.1M-1.56%131.74M1.44%144.07M-1.03%155.55M-1.03%155.55M-16.75%130.15M-25.55%133.82M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More